Document is current

Any future updates will be listed below

A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of FcγRIIA receptor

Crossref DOI link: https://doi.org/10.1038/s41401-024-01397-3

Published Online: 2024-10-16

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark